RBC iShares Launches Innovative New ETF Series
RBC iShares has made a notable advancement in the actively managed ETF market with the launch of two new ETF Series. Managed by RBC Global Asset Management Inc. (RBC GAM Inc.), these ETFs are set to begin trading on Cboe Canada shortly. This launch showcases RBC iShares' commitment to providing Canadian investors with a wide range of investment options.
New ETF Series Details
The newly launched ETF Series includes:
RBC Life Science and Technology Fund – ETF Series
This fund focuses on delivering long-term capital growth by primarily investing in equity securities of U.S. companies involved in the life sciences and technology sectors. It targets businesses making advancements in areas such as biotechnology, pharmaceuticals, and innovative technology.
RBC U.S. Mid-Cap Growth Equity Fund – ETF Series
This fund is dedicated to long-term capital appreciation, investing mainly in equity securities of U.S. mid-cap growth companies. It serves as a strong option for investors seeking to take advantage of the growth potential offered by mid-sized firms.
Understanding Active ETFs
The introduction of these two ETF Series aims to meet the changing needs of Canadian investors, especially those facing the complexities of building diversified investment portfolios. Mark Neill, managing director and head of RBC ETFs and Strategic Alliances at RBC GAM Inc., pointed out that investors encounter various challenges, such as home country bias and economic uncertainties. These actively managed ETFs offer a practical solution by providing new strategic investment opportunities.
With the expertise of RBC's dedicated North American Equity team, which manages over $80 billion in assets, investors can trust their deep insights and experience to guide these funds effectively.
RBC iShares’ Commitment to Client Success
RBC iShares is devoted to helping clients meet their financial goals while promoting effective portfolio construction. By enhancing the investment journey, RBC iShares aims to provide unique offerings that contribute to positive results for clients.
Those interested in diversifying their investments may find these new ETF Series appealing, as they combine innovation with high-quality management.
Company Overview: RBC
Royal Bank of Canada is one of the largest financial institutions worldwide, grounded in a purpose-driven ethos. With a diverse team of over 100,000 individuals and a clientele exceeding 18 million, RBC is committed to providing outstanding financial services. The bank’s focus on innovation ensures it remains attuned to client needs across Canada, the U.S., and beyond.
Future Growth and Community Engagement
RBC iShares understands the importance of community involvement through initiatives, including both donations and employee volunteering. Their comprehensive approach not only fosters community growth but also ensures clients have the financial resources necessary to navigate future economic challenges.
If you’re interested in learning more about RBC iShares ETFs, detailed information is readily accessible via their official platforms, helping investors make well-informed decisions.
Frequently Asked Questions
What are the newly launched ETF Series by RBC iShares?
RBC iShares has launched the RBC Life Science and Technology Fund and the RBC U.S. Mid-Cap Growth Equity Fund.
What is the management fee for the new ETF Series?
Both ETF Series carry a management fee of 0.75%.
What is the primary investment focus of the RBC Life Science and Technology Fund?
This fund primarily invests in U.S. equity securities within the life sciences and technology sectors.
Who manages these new ETFs?
The experienced team at RBC Global Asset Management Inc. is responsible for managing these funds with a focus on active management strategies.
How can I find more information about RBC iShares ETFs?
You can access more information through the RBC iShares official website, which provides comprehensive details about their investment offerings.
